|国家科技期刊平台
首页|期刊导航|中国药业|乌苏酸对人胰腺癌细胞PANC-1增殖和凋亡的影响

乌苏酸对人胰腺癌细胞PANC-1增殖和凋亡的影响OACSTPCD

Effects of Ursolic Acid on Proliferation and Apoptosis of Human Pancreatic Cancer Cell PANC-1

中文摘要英文摘要

目的 探讨乌苏酸对人胰腺癌细胞PANC-1 增殖、凋亡的影响.方法 以 1.25,2.5,5,10,25,50 μmol/L乌苏酸培养PANC-1细胞24,48,72 h,采用四氮唑盐(MTT)法测定细胞活性.实验分为对照1组(等体积二甲基亚砜)及乌苏酸低、中、高剂量组(5,10,20 μmol/L乌苏酸),显微镜下观察细胞形态,采用Western blot法检测磷脂酰肌醇 3 激酶(PI3K),磷酸化的蛋白激酶B(p-Akt),磷酸化哺乳动物雷帕霉素靶蛋白(p-mTOR),活化半胱氨酸蛋白酶 3(Cleaved Caspase-3),B淋巴细胞瘤-2(Bcl-2),Bcl-2 关联 X蛋白(Bax)的蛋白表达水平,采用细胞集落形成实验观察细胞增殖情况.实验分为对照 2 组(等体积二甲基亚砜)和乌苏酸组(10 μmol/L乌苏酸),采用细胞划痕实验观察细胞培养 48,72 h的迁移情况.利用分子对接实验模拟乌苏酸与PI3K和Akt2 的相互作用.结果 随着乌苏酸浓度的升高,PANC-1 细胞活性逐渐减弱,24,48,72 h时的半数抑制浓度(IC50)分别为 7.89,6.26,5.06 μmol/L.与对照 1 组比较,乌苏酸各剂量组细胞逐渐失去原有形态,且随着浓度的增加,变形细胞数目随之增加,且细胞边界模糊不清;细胞数量显著减少(P<0.05);乌苏酸各剂量组细胞Cleaved Caspase-3、Bax蛋白的表达水平均显著升高,乌苏酸中、高剂量组细胞Bcl-2蛋白表达水平显著降低,乌苏酸各剂量组细胞p-mTOR,中、高剂量组细胞p-Akt,高剂量组细胞PI3K蛋白表达水平均显著降低(P<0.05).与对照 2 组比较,乌苏酸组细胞 48 h,72 h的迁移距离缩短.乌苏酸的乌苏烷型三萜类结构可进入PI3K与Akt2 中的三磷酸腺苷(ATP)结合位点竞争性结合疏水口袋,从而影响PI3K和Akt2 与ATP的结合,抑制其激活.结论 乌苏酸可通过抑制PI3K/Akt/mTOR信号通路的激活而抑制PANC-1 细胞的增殖,促进其凋亡.

Objective To investigate the effects of ursolic acid on the proliferation and apoptosis of human pancreatic cancer cell PANC-1.Methods PANC-1 cells were cultured with 1.25,2.5,5,10,25 and 50 μmol/L ursolic acid for 24,48 and 72 h,and the cell viability was measured by the methyl thiazolyl tetrazolium(MTT)method.PANC-1 cells were divided into the control group one(equal volume of dimethyl sulfoxide)and the ursolic acid low-,medium-and high-dose groups(5,10 and 20 μmol/L ursolic acid),the cell morphology was observed by microscope,the expression levels of phosphatidylinositol 3-kinase(PI3K),phosphorylated-protein kinase B(p-Akt),phosphorylated-mammalian target of rapamycin(p-mTOR),Cleaved Caspase-3,B-cell lymphoma-2(Bcl-2),Bcl-2-associated X(Bax)proteins were detected by the Western blot,and the cell proliferation was observed by the colony formation assay.PANC-1 cells were divided into the control group two(equal volume of dimethyl sulfoxide)and the ursolic acid group(10 μmol/L ursolic acid),the cell migration was observed by the wound healing assay after 48 and 72 h of culture.The interaction of ursolic acid with PI3K and Akt2 proteins was simulated by the molecular docking.Results As the concentration of ursolic acid increased,the viability of PANC-1 cells gradually weakened,with the half-inhibitory concentrations(IC50)of 7.89,6.26 and 5.06 μmol/L at 24,48 and 72 h,respectively.Compared with those in the control group one,the cell morphology in the ursolic acid low-,medium-and high-dose groups was abnormal,with the increase of concentration,the number of deformed cells increased,and the cell boundaries became blurred;the number of cells also significantly decreased(P<0.05).Compared with those in the control group one,the expression levels of Cleaved Caspase-3 and Bax proteins in each dose group of ursolic acid significantly increased;the expression level of Bcl-2 protein in the ursolic acid medium-and high-dose groups significantly decreased;the expression levels of p-mTOR protein in the ursolic acid low-,medium-and high-dose groups,p-Akt protein in the ursolic acid medium-and high-dose groups,and PI3K protein in the ursolic acid high-dose group significantly decreased(P<0.05).Compared with that in the control group two,the migration distance in the ursolic acid group shortened after 48 and 72 h of culture.The ursane triterpenoid structure of ursolic acid can enter into a hydrophobic pocket of PI3K and Akt2 competitively binding with adenosine triphosphate(ATP)and occupy the ATP binding site,thereby interfering with the binding of PI3K and Akt2 to ATP and inhibiting their activation.Conclusion Ursolic acid can inhibit the proliferation of PANC-1 cells and promote their apoptosis by inhibiting the activation of the PI3K/Akt/mTOR signaling pathway.

金俊华;赵承伟;付佳;郑桂茹

浙江省金华市人民医院药剂科,浙江 金华 321000温州医科大学药学院<诸暨>生物医药研究院,浙江 诸暨 311800

药学

乌苏酸人胰腺癌细胞PANC-1PI3K/Akt/mTOR信号通路细胞凋亡

ursolic acidhuman pancreatic cancer cell PANC-1PI3K/Akt/mTOR signaling pathwayapoptosis

《中国药业》 2024 (002)

46-51 / 6

浙江省药学会医院药学专项科研资助项目[2019ZYY52];浙江省金华市科学技术研究计划项目[2020-4-026].

10.3969/j.issn.1006-4931.2024.02.011

评论